iodoxamate meglumine
Trade name: cholovue
Small moleculeapproved
Approved
Aug 14, 1981
Iodoxamic acid (previously sold under the brand name Cholovue) is an organoiodine compound that was used as a contrast medium. It is intravenous cholecystocholangiographic agent. It features both a high iodine content as well as several hydrophilic groups. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
Indications
Approved for
Mechanism of action
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedAug 14, 1981
Chemistry & pharmacology
Loading structure…
SMILES
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(CCOCCOCCOCCOCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc2c(I)cc(I)c(C(=O)O)c2I- Mol. weight
- 1680.37 g/mol
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL3989524 ↗
- NCATSNS1Y283HW4 ↗
- ChEMBLCHEMBL4594231 ↗
- ChEMBLCHEMBL1615487 ↗
- ChEMBLCHEMBL1201324 ↗
- ChEMBLCHEMBL1200669 ↗
Also known as
- 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-dily)diimino)bis(2,4,6-triiodobenzoic acid)
- b 10610
- b-10610
- bc 17
- bc-17
- cholovue
- cholovue
- cholovue
- cholovue
- endobil
- endomirabil
- iodoxamate
- iodoxamate
- iodoxamate
- iodoxamate
- iodoxamate
- iodoxamate meglumine
- iodoxamate meglumine
- iodoxamate meglumine
- iodoxamate meglumine
- iodoxamate meglumine
- iodoxamic acid
- iodoxamic acid
- iodoxamic acid
- iodoxamic acid, calcium salt
- iodoxamic acid, magnesium salt
- iodoxamic acid meglumine salt
- iodoxamic acid meglumine salt
- iodoxamid
- iodoxamidic acid
- iodoxaminic acid
- methylglucamine iodoxamate